Literature DB >> 8929286

Effects of polymyxin B on mammalian urinary bladder.

J R Berg1, C M Spilker, S A Lewis.   

Abstract

Previous reports have demonstrated that large cationic polypeptides (of molecular mass 5,000 daltons or greater) cause an increase in the apical membrane conductance of the rabbit urinary bladder epithelium. This report investigates the effects of the small cationic molecule polymyxin B (PX: a 1,400 dalton antibiotic) on the permeability of the rabbit urinary bladder. The addition of micromolar concentrations of polymyxin B to the luminal solution of the rabbit urinary bladder resulted in an increase in the transepithelial conductance of the bladder. The magnitude of the increase in the conductance was dependent upon the concentration of PX, and the polarity and magnitude of the apical membrane potential. As the apical membrane potential was made more cell interior negative, the larger was the increase in the membrane conductance. This voltage-dependent increase in conductance was an exponential function of the applied voltage, with a negligible increase in conductance occurring when the membrane potential was cell interior positive. Upon changing the membrane voltage from cell interior positive to negative, there was a delay before there was a measurable change in the membrane conductance. The longer the apical membrane was exposed to PX, the more poorly reversible was its effect on the transepithelial conductance, suggesting a toxic effect of PX on this epithelium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929286     DOI: 10.1007/s002329900137

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  9 in total

Review 1.  The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.

Authors:  Matthew E Falagas; Sofia K Kasiakou; Sotirios Tsiodras; Argyris Michalopoulos
Journal:  Clin Med Res       Date:  2006-06

Review 2.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

3.  Efficacy and Safety of Intravenous Colistin in Very Low Birth Weight Preterm Infants.

Authors:  Ozkan Ilhan; Meltem Bor; Senem Alkan Ozdemir; Sinem Akbay; Esra Arun Ozer
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

4.  Structure-activity relationships for the binding of polymyxins with human α-1-acid glycoprotein.

Authors:  Mohammad A K Azad; Johnny X Huang; Matthew A Cooper; Kade D Roberts; Philip E Thompson; Roger L Nation; Jian Li; Tony Velkov
Journal:  Biochem Pharmacol       Date:  2012-05-12       Impact factor: 5.858

5.  High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

Authors:  Lidia Dalfino; Filomena Puntillo; Adriana Mosca; Rosa Monno; Maria Luigia Spada; Sara Coppolecchia; Giuseppe Miragliotta; Francesco Bruno; Nicola Brienza
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

Review 6.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

7.  Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.

Authors:  Akshay Sabnis; Katheryn Lh Hagart; Anna Klöckner; Michele Becce; Lindsay E Evans; R Christopher D Furniss; Despoina Ai Mavridou; Ronan Murphy; Molly M Stevens; Jane C Davies; Gérald J Larrouy-Maumus; Thomas B Clarke; Andrew M Edwards
Journal:  Elife       Date:  2021-04-06       Impact factor: 8.140

8.  Inhibition of lipopolysaccharide-induced suppression of luteal function in isolated perfused bovine ovaries.

Authors:  Elena Storni; Heinrich Bollwein; Anna-Katharina Hankele; Olga Wellnitz; Rupert M Bruckmaier; Susanne E Ulbrich; Johannes Lüttgenau
Journal:  J Reprod Dev       Date:  2021-11-02       Impact factor: 2.214

9.  Evaluation of risk of nephrotoxicity with high dose, extended-interval colistin administration.

Authors:  Arun Dewan; Mujeeb Shoukat
Journal:  Indian J Crit Care Med       Date:  2014-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.